158 related articles for article (PubMed ID: 21401902)
1. The phenotypic and genetic assessment of antithrombin deficiency.
Cooper PC; Coath F; Daly ME; Makris M
Int J Lab Hematol; 2011 Jun; 33(3):227-37. PubMed ID: 21401902
[TBL] [Abstract][Full Text] [Related]
2. Great discrepancy in antithrombin activity measured using five commercially available functional assays.
Javela K; Engelbarth S; Hiltunen L; Mustonen P; Puurunen M
Thromb Res; 2013 Jul; 132(1):132-7. PubMed ID: 23768451
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratio.
Moore GW; de Jager N; Cutler JA
Thromb Res; 2015 Jan; 135(1):161-6. PubMed ID: 25466846
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.
Orlando C; Heylen O; Lissens W; Jochmans K
Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin.
Hepner M; Karlaftis V
Methods Mol Biol; 2013; 992():355-64. PubMed ID: 23546728
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis of hereditary thrombophilia.
Michiels JJ; Hamulyák K
Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
[TBL] [Abstract][Full Text] [Related]
9. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
[TBL] [Abstract][Full Text] [Related]
10. Inherited antithrombin deficiency: a review.
Patnaik MM; Moll S
Haemophilia; 2008 Nov; 14(6):1229-39. PubMed ID: 19141163
[TBL] [Abstract][Full Text] [Related]
11. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
[No Abstract] [Full Text] [Related]
12. The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency.
Kovács B; Bereczky Z; Oláh Z; Gindele R; Kerényi A; Selmeczi A; Boda Z; Muszbek L
Am J Clin Pathol; 2013 Nov; 140(5):675-9. PubMed ID: 24124146
[TBL] [Abstract][Full Text] [Related]
13. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
[TBL] [Abstract][Full Text] [Related]
14. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
[TBL] [Abstract][Full Text] [Related]
15. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
16. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin Cambridge II(A384S) mutation frequency and antithrombin activity levels in 120 of deep venous thrombosis and 150 of cerebral infarction patients in a single center in Southern China.
Zhang GS; Tang YM; Tang MQ; Qing ZJ; Shu C; Tang XQ; Deng MY; Tan LM
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):588-91. PubMed ID: 20683322
[TBL] [Abstract][Full Text] [Related]
18. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study].
Ye X; Feng Y; Jin PP; Zhou XH; Ding QL; Wang XF
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812
[TBL] [Abstract][Full Text] [Related]
19. Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on α and β forms.
Amiral J; Seghatchian J
Transfus Apher Sci; 2018 Apr; 57(2):291-297. PubMed ID: 29784539
[TBL] [Abstract][Full Text] [Related]
20. Role of the C-sheet in the maturation of N-glycans on antithrombin: functional relevance of pleiotropic mutations.
Aguila S; Navarro-Fernández J; Bohdan N; Gutiérrez-Gallego R; de la Morena-Barrio ME; Vicente V; Corral J; Martínez-Martínez I
J Thromb Haemost; 2014 Jul; 12(7):1131-40. PubMed ID: 24824609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
